3E Bioventures
5AM Ventures 82VS AbbVie, Inc. Accequa AB Aclipse Therapeutics Actinogen Medical Ltd. AcureX Therapeutics adMare BioInnovations age1 Fund I GP, LLC Agile Capital Markets AGTC Ventures LLC ALCEDIAG Alpha Bronze Alta Global Ventures Alterity Therapeutics Alto Neuroscience, Inc. Amyl Therapeutics Andera Partners Angelini Ventures Aqua Partners LLC Argobio Studio Aruna Bio, Inc. ASDERA LLC atai Life Sciences N.V. ATEM Capital Avestria Ventures B'IMPRESS - impressive communication BERNINA BioInvest Ltd. BioAge Labs, Inc. BioCentury, Inc. Biogen Bionaut Labs Bioqube Ventures Bioscience Managers Pty Ltd BIOSTART Consulting GmbH BioSymetrics, Inc. Blackstone Life Sciences Boehringer Ingelheim International GmbH Bradley Woods & Co. Ltd. Braintale Brandon Capital BTIG, LLC Canaccord Genuity LLC Cantor Fitzgerald Capital Family Office Cassel Salpeter & Co., LLC CBT Advisors Cenna Biosciences, Inc. Centre for Aging + Brain Health Innovation (CABHI) Cerecin Inc. China Grand Enterprises, Inc. Class Bravo Ventures Clexio Biosciences Cognesy Therapeutics Cognition Therapeutics, Inc. Complement Therapeutics Ltd Consilium Strategic Communications Cota Capital Crosswave Management, Inc. CTI Life Sciences Cukierman & Co. Investment House Ltd. Cukierman & Co. Life Sciences Daiichi Sankyo David Fox Syndicate DCVC Bio Deerfield Management DEFTA Partners DigiTx Partners Dorset Capital LLC Droia Ventures Edison Group EF Hutton Eight Roads Ventures Eikonizo Therapeutics, Inc EIP Pharma, Inc. Eli Lilly and Company Emyria Enveric BioSciences, Inc. EQT Life Sciences EryDel SpA ESP Diagnostics Limited Evecxia Therapeutics, Inc. F. Hoffmann-La Roche Ltd. Ferghana Partners, Inc. Find Therapeutics Inc. Forbion Forty51 Ventures Fraser Finance LLP Freedom Capital Markets FreeMind Group Fundación de Neurociencias Gate Neurosciences, Inc. Gen2 Neuroscience Ltd Generation Fund Life Sciences Fund I GeNeuro SA Gilgamesh Pharmaceuticals Gimv Global Emerging Markets (GEM) Good Health Capital GreenSky Capital, Inc. Gryphon Bio, Inc. H. Lundbeck A/S H.C. Wainwright & Co. Hanall Pharmaceutical International Inc. Hatteras Venture Partners HBM Partners AG Health Innovation Capital HEDA Ventures Herantis Pharma Plc Hestia Investments Ltd. High-Tech Gründerfonds Management GmbH Hunniwell Lake Ventures LLC IDG Capital Partners Ignite Capital Partners, Inc. Illumina Accelerator Illumina Ventures IMMvention Therapeutix, Inc. Impact India Investment Partners, LLC Indaco Venture Partners SGR S.p.A. Independent InGel Therapeutics, Inc. Intermediate Capital Group PLC Inveready Asset Management Invest Hong Kong IPF Management S.A. Ipsen IRLAB Therapeutics AB Janssen Research & Development, LLC JCR Pharmaceuticals Jeito Capital JLS Fund LP Johnson & Johnson Innovation – JJDC, Inc. Last updated on: 13th of January
|
Johnson & Johnson Innovation LLC
Johnston Associates JPMorgan Chase & Co. JT Pharma Kaleida Capital Katan Associates KeifeRx Keystone Bio, Inc. Korys Investments NV Kures, Inc. Ladenburg Thalmann & Co. Inc. Landmark Angels, Inc. Leaps by Bayer LikeMinds Lilly Asia Ventures LMU Munich LongeVC Longevity Biotech, Inc. Lucia Capital Lumanity Lumira Ventures Lundbeckfonden BioCapital Ventures M Ventures Mass General Brigham Ventures MedTech Strategist Merck & Co., Inc. Mid Atlantic Bio Angels Monument Therapeutics Limited MUFG Union Bank, N.A. National Institute of Neurological Disorders and Stroke (NINDS), NIH National Institute on Aging Neuraly Inc. Neuro-Innovators, LLC Neuromod Devices NeuroPn Therapeutics Neuroscience Trials Australia Neurotech Reports Neurovascular Research & Design Neurvati Neurosciences, Inc. New Harbor Venture Partners, LLC New Science Global Healthcare Fund NI Research Inc. Noble Life Science Partners Noema Pharma AG Novartis AG Novo Holdings NRx Pharmaceuticals, Inc. Oceaniq Capital Oculis SA OcuTerra Therapeutics OcuTerra Therapeutics Inc. Ontario Brain Institute Ontario Teachers' Pension Plan Board Oppenheimer & Co. Inc. Optimum Strategic Communications OrbiMed Advisors LLC Oryzon Genomics, S.A. Osage University Partners Palo Alto Investors Panakès Partners SGR SpA Pangea Botania Ltd Pappas Capital Pepper Bio Perceptive Advisors, LLC Pharmaphorum Media Limited PharmaVentures Ltd. PJT Partners Praesidia Biotherapeutics, Inc. Prevail Partners LLC Primary Peptides Inc. Pritzker Neuropsychiatric Disorders Research Consortium Profound Ventures Prothena Corporation Protobios Psilera Inc. Pureos Bioventures Qiming Venture Partners Qynapse, Inc. Ray Therapeutics, Inc. Raya Therapeutic re.Mind Capital Ltd. Recode Health Ventures Remiges Ventures, Inc. ReST THERAPEUTICS Robeauté Roth Capital Partners, LLC Rune Labs, Inc. RYSE Asset Management Sand Hill Angels Sandman Financial Seventure Partners Shadow Lake Group Inc. Silicon Valley Bank Silicon Valley Ventures Simcere Pharmaceutical Group Sixty Degree Capital Sofinnova Investments, Inc. Sofinnova Partners Sony Innovation Fund Sound Bioventures Management AB SR One STALICLA SA SternAegis Ventures Stifel Europe SV Health Investors LLP Takeda Development Center Americas, Inc. Talu Ventures The Benchmark Company, LLC The Centre for Addiction & Mental Health (CAMH) The Michael J. Fox Foundation for Parkinson's Research Theranexus S.A. TikoMed AB Torreya Treo Ventures TruVenturo GmbH Twin Oaks Capital, LLC Unlearn.AI, Inc. V-Bio Ventures Valor Management S.A. Ventac Partners A/S Venture Valuation Vine Ventures Real LLC Vista Capital Advisors, LLC Viva BioInnovator WBB Securities, LLC Wellington Partners Wells Fargo Bank N.A. WISE S.r.l. WPSS.bio WRF Capital XOventure GmbH More TBA... |
6TH ANNUAL NEUROSCIENCE INNOVATION FORUM
FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT
8TH JANUARY 2023 | MARINES' MEMORIAL CLUB | SAN FRANCISCO | USA
ATTENDEES AT THE #Sachs_NIF FORUM
Sachs Associates Switzerland AG
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: [email protected]
© COPYRIGHT 2023. ALL RIGHTS RESERVED.